PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Product: Epilim
Presentation Product Chemical substance Chapter Items dispensed
Epilim Chrono 500 tablets
0408010W0BBALA2
Epilim Sodium valproate Central Nervous System 85,776
Epilim Chrono 300 tablets
0408010W0BBAKA1
Epilim Sodium valproate Central Nervous System 61,564
Epilim Chrono 200 tablets
0408010W0BBAJAZ
Epilim Sodium valproate Central Nervous System 51,897
Epilim 200 gastro-resistant tablets
0408010W0BBABAC
Epilim Sodium valproate Central Nervous System 33,832
Epilim 500 gastro-resistant tablets
0408010W0BBACAD
Epilim Sodium valproate Central Nervous System 33,325
Epilim 200mg/5ml liquid
0408010W0BBADAA
Epilim Sodium valproate Central Nervous System 26,082
Epilim 100mg crushable tablets
0408010W0BBAAAB
Epilim Sodium valproate Central Nervous System 10,702
Epilim 200mg/5ml syrup
0408010W0BBAEAE
Epilim Sodium valproate Central Nervous System 3,809
Epilim Chronosphere MR 500mg granules sachets
0408010W0BBAMBS
Epilim Sodium valproate Central Nervous System 3,475
Epilim Chronosphere MR 100mg granules sachets
0408010W0BBAPBW
Epilim Sodium valproate Central Nervous System 2,782
Epilim Chronosphere MR 1000mg granules sachets
0408010W0BBASBT
Epilim Sodium valproate Central Nervous System 2,113
Epilim Chronosphere MR 250mg granules sachets
0408010W0BBAQBX
Epilim Sodium valproate Central Nervous System 1,641
Epilim Chronosphere MR 750mg granules sachets
0408010W0BBARBY
Epilim Sodium valproate Central Nervous System 1,134
Epilim Chronosphere MR 50mg granules sachets
0408010W0BBANBV
Epilim Sodium valproate Central Nervous System 826
Epilim Intravenous 400mg inj vials
0408010W0BBAIAH
Epilim Sodium valproate Central Nervous System 3

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.